These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 37442822)

  • 1. Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia region.
    Sticchi Damiani A; Zizza A; Banchelli F; Gigante M; De Feo ML; Ostuni A; Marinelli V; Quagnano S; Negro P; Di Renzo N; Guido M;
    Ann Hematol; 2023 Oct; 102(10):2923-2931. PubMed ID: 37442822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
    Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
    Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation.
    Martinez-Acuña N; Avalos-Nolazco DM; Rodriguez-Rodriguez DR; Martinez-Liu CG; Galan-Huerta KA; Padilla-Rivas GR; Ramos-Jimenez J; Ayala-de-la-Cruz S; Cienfuegos-Pecina E; Diaz-Chuc EA; Cazares-Tamez R; Flores-Arechiga A; Perez-Chavez F; Arellanos-Soto D; Lozano-Sepulveda SA; Garza-Gonzalez E; Treviño-Garza C; Montes-de-Oca-Luna R; Lee-Gonzalez AB; de-la-O-Cavazos ME; Rivas-Estilla AM
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34202849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of correlation between ABO Rh(D) blood group and neutralizing antibody titers in SARS-CoV-2 convalescent plasma donors.
    Hirani R; Hoad V; Gosbell IB; Irving DO
    Transfusion; 2022 Feb; 62(2):292-297. PubMed ID: 34936102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG antibodies to SARS-CoV-2 in asymptomatic blood donors at two time points in Karachi.
    Hasan M; Moiz B; Qaiser S; Masood KI; Ghous Z; Hussain A; Ali N; Simas JP; Veldhoen M; Alves P; Abidi SH; Ghias K; Khan E; Hasan Z
    PLoS One; 2022; 17(8):e0271259. PubMed ID: 36001587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of SARS-CoV-2 among potential convalescent plasma donors and analysis of their deferral pattern: Experience from tertiary care hospital in western India.
    Jain R; Mallya MV; Amoncar S; Palyekar S; Adsul HP; Kumar R; Chawla S
    Transfus Clin Biol; 2022 Feb; 29(1):60-64. PubMed ID: 34302953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of antibodies to SARS-CoV-2 among blood donors in the early months of the pandemic in Saudi Arabia.
    Banjar A; Al-Tawfiq JA; Alruwaily A; Alserehi H; Al-Qunaibet A; Alaswad R; Almutlaq H; Almudaiheem A; Khojah AT; Alsaif F; Almolad SK; Alqahtani S; AlJurayyan A; Alotaibi A; Almalki S; Abuhaimed Y; Alkhashan A; Alfaifi A; Alabdulkareem K; Jokhdar H; Assiri A; Almudarra S
    Int J Infect Dis; 2021 Mar; 104():452-457. PubMed ID: 33465488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression and Predictors of SARS-CoV-2 Antibody Seroreactivity In US Blood Donors.
    Vassallo RR; Dumont LJ; Bravo MD; Hazegh K; Kamel H
    Transfus Med Rev; 2021 Jul; 35(3):8-15. PubMed ID: 34376289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABO blood group and SARS-CoV-2 antibody response in a convalescent donor population.
    Bloch EM; Patel EU; Marshall C; Littlefield K; Goel R; Grossman BJ; Winters JL; Shrestha R; Burgess I; Laeyendecker O; Shoham S; Sullivan D; Gehrie EA; Redd AD; Quinn TC; Casadevall A; Pekosz A; Tobian AAR
    Vox Sang; 2021 Aug; 116(7):766-773. PubMed ID: 33493365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of US Blood Donors Testing Reactive for Antibodies to SARS-CoV-2 Prior to the Availability of Authorized Vaccines.
    Dodd RY; Spencer BR; Xu M; Foster GA; Saá P; Brodsky JP; Stramer SL
    Transfus Med Rev; 2021 Jul; 35(3):1-7. PubMed ID: 34373145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of SARS-CoV-2 IgG antibody among healthy blood donors: a single centre study.
    Jaiswal R; Sharma S; Singla A; Devpura N; Vohra R; Kakkar M; Rijhwani P; Sureka R
    Transfus Apher Sci; 2022 Jun; 61(3):103338. PubMed ID: 34933819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
    Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
    JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-Coronavirus-2 seroprevalence in asymptomatic healthy blood donors: Indicator of community spread.
    Kale P; Patel N; Gupta E; Bajpai M
    Transfus Apher Sci; 2022 Feb; 61(1):103293. PubMed ID: 34686444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico.
    Monteón V; Pérez FL; Hernández VP; Pacheco AO; Guzman PF; Torres GIG
    Transfus Apher Sci; 2022 Jun; 61(3):103374. PubMed ID: 35101375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the ABO blood group with SARS-CoV-2 infection in a community with low infection rate.
    Kotila TR; Alonge TO; Fowotade A; Famuyiwa OI; Akinbile AS
    Vox Sang; 2021 Sep; 116(8):910-915. PubMed ID: 33529391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of SARS-CoV-2 antibodies among blood donors in Québec: an update from a serial cross-sectional study.
    Lewin A; De Serres G; Grégoire Y; Perreault J; Drouin M; Fournier MJ; Tremblay T; Beaudoin J; Boivin A; Goyette G; Finzi A; Bazin R; Germain M; Delage G; Renaud C
    Can J Public Health; 2022 Jun; 113(3):385-393. PubMed ID: 35380364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood group O convalescent plasma donations have significantly lower levels of SARS-CoV-2 IgG antibodies compared to blood group A donations.
    Hayes C; Rubenstein W; Gibb D; Klapper E; Tanaka J; Pepkowitz S
    Transfusion; 2021 Aug; 61(8):2245-2249. PubMed ID: 34036595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends and risk factors of SARS-CoV-2 infection in asymptomatic blood donors.
    Valenti L; Pelusi S; Cherubini A; Bianco C; Ronzoni L; Uceda Renteria S; Coluccio E; Berzuini A; Lombardi A; Terranova L; Malvestiti F; Lamorte G; Erba E; Oggioni M; Ceriotti F; Prati D
    Transfusion; 2021 Dec; 61(12):3381-3389. PubMed ID: 34647620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study.
    Ray JG; Schull MJ; Vermeulen MJ; Park AL
    Ann Intern Med; 2021 Mar; 174(3):308-315. PubMed ID: 33226859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seropositivity in blood donors and pregnant women during the first year of SARS-CoV-2 transmission in Stockholm, Sweden.
    Castro Dopico X; Muschiol S; Christian M; Hanke L; Sheward DJ; Grinberg NF; Rorbach J; Bogdanovic G; Mcinerney GM; Allander T; Wallace C; Murrell B; Albert J; Karlsson Hedestam GB
    J Intern Med; 2021 Sep; 290(3):666-676. PubMed ID: 34008203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.